Dr. Peter T. Sage is an Associate Professor of Medicine at Harvard Medical School and an Associate Immunologist at Brigham and Women’s Hospital. With a distinguished career in immunology, Dr. Sage’s research focuses on the complex interplay between T cells and B cells in health and disease, with particular emphasis on autoimmune conditions and transplantation. His groundbreaking work on follicular regulatory T cells (Tfr) and follicular helper T cells (Tfh) has significantly advanced our understanding of how these subsets modulate immune responses, driving innovation in cellular immunotherapy.
As a member of the Scientific Advisory Board, Dr. Sage plays a critical role in advancing cutting-edge cell and gene therapy programs. His expertise is particularly instrumental in helping us design strategies to stabilize and engineer regulatory T cells (Tregs) for addressing autoimmune diseases. His insights ensure that our initiatives are rooted in rigorous, clinically relevant science, fostering transformative outcomes for patients.
Dr. Sage earned his PhD in Immunology from Harvard Medical School and has received numerous accolades for his contributions to the field. His unwavering commitment to bridging foundational research with therapeutic innovation aligns with our mission to transform healthcare and shape a future free from chronic diseases.